Skip to main content
. Author manuscript; available in PMC: 2022 Jul 11.
Published in final edited form as: Oral Oncol. 2020 Dec 22;113:105125. doi: 10.1016/j.oraloncology.2020.105125

Fig. 3.

Fig. 3.

Overall survival for 132 patients with HPV associated oropharyngeal cancer who developed recurrent disease. Patients are grouped by solitary (including oligo-metastasis) versus multiple sites of recurrence.